Navigation Links
Kosan's Board of Directors Appoints Helen S. Kim as Chief Executive Officer
Date:3/18/2008

ential and other characteristics of Kosan's product candidates; the continuation of current clinical trials; the initiation of additional clinical trials and the timing thereof and the use of Kosan's financial resources. Words such as "will," "expect," "believe," "may," "intend," "plan," "potential" and similar expressions are intended to identify forward-looking statements. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. These forward-looking statements are based upon Kosan's current expectations. Forward-looking statements involve risks and uncertainties. Kosan's actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to the uncertain progress and results of Kosan's preclinical and clinical testing, including the risks that studies and trials may not demonstrate safety and efficacy sufficient to initiate clinical trials on the timing currently anticipated, or at all, continue clinical development, obtain the requisite regulatory approvals or result in a marketable product; the conduct of clinical trials; manufacturing; regulatory approval requirements and process; the effort and expense necessary for further development of Kosan's product candidates, including the costs of bortezomib; intellectual property matters, including Kosan's ability to obtain valid and enforceable patents covering its product candidates; Kosan's dependence on its collaboration with Pfizer for development of its motilin agonist product candidate; Kosan's need for additional financing and Kosan's strategy to enter into partnering or licensing arrangements. These and other risk factors are discussed under "Risk Factors" in Kosan's Annual Report on Form 10-K for the year ended December 31, 2007 and other periodic filings with the SEC. Kosan expres
'/>"/>
SOURCE Kosan Biosciences Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
2. KGI Elects Three New Members to Board of Trustees
3. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
4. DOV Pharmaceutical, Inc. Begins Trading on OTC Bulletin Board
5. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
6. BioLife Solutions Expands Scientific Advisory Board
7. NeurogesX Appoints New Director to the Board
8. Genstar Names Michael Hurt to Its Strategic Advisory Board
9. Boston Scientific Announces Election of Ray Elliott to Its Board of Directors
10. Bruce Pasternack Elected to Codexis Board
11. Interleukin Genetics Announces Management and Board Appointments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... researchers led by Northeastern University has developed a ... and a variety of nanocarbon structures in carbon ... scalable, which will allow the researchers to tailor ... in applications ranging from electronic devices to CNT-reinforced ... sports equipment. , Their findings were published in ...
(Date:9/15/2014)... DUBLIN , Sept. 15, 2014 Research ... "Whole Exome Sequencing Market by Product, by Services, by Technology, ... their offering. Whole Exome Sequencing (WES) is ... the genome, i.e. the exon. The exome, which is the ... of the total genome and is actually converted into proteins ...
(Date:9/15/2014)... , 15 septembre 2014 La ... Week (IPAW) (semaine internationale sur la sensibilisation ... octobre. Initiative conjointe de la Plasma Protein ... sociétés membres , l,IPAW vise à : ... sujet de la collecte du plasma-aphérèse , ...
(Date:9/14/2014)... 2014 UMBC’s Biotechnology Graduate Programs’ ... October 21, 2014, from 12:00 to 1:00 p.m. EDT. ... innovative curriculum and practice-oriented instruction, designed for working professionals. ... help advance their career in the biotechnology industry. , ... , About UMBC’s Biotechnology Graduate Programs, UMBC offers ...
Breaking Biology Technology:Northeastern University Researchers Develop Novel Method for Working with Nanotubes 2Global Whole Exome Sequencing (Systems, Kits, Library Preparation, Target Enrichment) Market by Product, by Services, by Technology, by Application - Forecast to 2018 2Global Whole Exome Sequencing (Systems, Kits, Library Preparation, Target Enrichment) Market by Product, by Services, by Technology, by Application - Forecast to 2018 3L' International Plasma Awareness Week célébrera les donneurs et braquera les projecteurs sur les maladies rares 2L' International Plasma Awareness Week célébrera les donneurs et braquera les projecteurs sur les maladies rares 3UMBC Biotechnology Graduate Programs’ Virtual Info Session, October 21, 2014 2
... INDIANAPOLIS, and SAN DIEGO, July 8 Eli Lilly,and ... (Nasdaq: SGXP ) today,announced that the companies have ... SGX in an all-cash transaction. SGX, based,in San Diego, ... development in the area of oncology. Under the terms ...
... in diagnostics, imaging, and ... ... Institute, and Case Western Reserve University today,announced the organizations will partner ... diagnostics, imaging and therapeutics,to improve medical treatment and patient care., ...
... July 8 Royalty Pharma is pleased to announce,that ... Vice,President, Head of Research. Dr. Reddoch has 17 years ... last 12 years as an equity analyst,most recently as ... Markets. He previously worked at Banc of America,Securities, and ...
Cached Biology Technology:Lilly to Acquire SGX Pharmaceuticals 2Lilly to Acquire SGX Pharmaceuticals 3Lilly to Acquire SGX Pharmaceuticals 4Lilly to Acquire SGX Pharmaceuticals 5NanoMedicine Summit Returns to Cleveland, September 25-26 2NanoMedicine Summit Returns to Cleveland, September 25-26 3NanoMedicine Summit Returns to Cleveland, September 25-26 4Royalty Pharma Announces that James Reddoch, Ph.D., Joins Management Team 2
(Date:9/15/2014)... GEOMAR Helmholtz Centre for Ocean Research Kiel and ... for the first time, that the single most ... Emiliania huxleyi , can adapt simultaneously to ocean ... the researchers found no evidence for the widespread ... of climate change would interfere with each other. ...
(Date:9/15/2014)... 100 feet long and weighing as much as 170 tons, ... and by far the heaviest living thing ever seen on ... common with the tiniest fish larvae, which measure millimeters in ... gram, right? , Not so fast, says L. Mahadevan, ... Organismic and Evolutionary Biology, and of Physics. , Using ...
(Date:9/15/2014)... , , , ... , , , , ... set of symptoms. The finding could be a first... , , ... , , , , , ... , , , , , , , New research shows that schizophrenia isn,t ...
Breaking Biology News(10 mins):Small algae with great potential 2Small algae with great potential 3The science behind swimming 2The science behind swimming 3Schizophrenia not a single disease but multiple genetically distinct disorders 2Schizophrenia not a single disease but multiple genetically distinct disorders 3Schizophrenia not a single disease but multiple genetically distinct disorders 4Schizophrenia not a single disease but multiple genetically distinct disorders 5
... can affect healthy people,s personality traits as well as ... reveals a thesis from the University of Gothenburg, Sweden. ... is responsible for defending humans against infection as well ... vital for our survival. Research has demonstrated that inflammatory ...
... for the French National Institute for Agricultural Research INRA ... Apidologie , Annals of Forest Sciences , ... Sustainable Development and Veterinary Research (all ... published by the prestigious institute have gained an excellent ...
... the lower the risk of developing low- and high-grade ... Biomarkers & Prevention , a journal of the American ... of Illinois at Chicago, used self-reported data on medically ... glioma and 612 cancer-free patients from Duke University and ...
Cached Biology News:Genes of the immune system are associated with increased risk of mental illness 2Springer and the French National Institute for Agricultural Research INRA team up 2Allergies lower risk of low- and high-grade glioma 2
...
... Monoclonal Anti-β-Tubulin IV Recognizes an ... sequence of β-tubulin isotype IV. ... isotypes is observed. ascites fluid ... C-terminal sequence of β-tubulin isotype ...
... Finnpipette BioControl is a major step ... complete liquid handling system - with ... tip cone modules. All five single ... modules fit one handle. The lightweight ...
... the joining of two strands of DNA ... of adjacent nucleotides in either a cohesive-ended ... also been shown to catalyze the joining ... RNA strand in a duplex molecule but ...
Biology Products: